Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Grant or award Chf Scientific Operations Off acquired 14,100 shares (grant or award)
  2. 4 Grant or award CEO and President acquired 42,300 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 14,100 shares (grant or award)
  4. 4 Open-market buy 10% owner bought 11,591 shares at an average $6.60 ($76,498)
  5. 4 Open-market buy 10% owner bought 38,000 shares at an average $6.53 ($248,293)
  6. 4 Open-market buy 10% owner bought 703 shares at $6.49 ($4,562)
  7. 4 Open-market buy 10% owner bought 10,353 shares at an average $6.46 ($66,899)
  8. 4 Open-market buy 10% owner bought 24,324 shares at an average $6.98 ($169,774)
  9. 4 Open-market buy 10% owner bought 6,557 shares at $6.50 ($42,621)
  10. 4 Open-market buy Chief Medical Officer bought 9,893 shares at an average $10.10 ($99,968)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3/A Insider 3/A

Page 8 of 20 · 382 filings